Comparing the results shown in Fig. 6D for ICI 182,780 (40.3% reduction) and PHTPP (51% reduction), tamoxifen only has 17.8% efficacy with respect to the reduction of ERβ(+) RCC tumor weight (Fig. 6E). Here, ESR2 is linked to renal cell carcinoma.